Some genomic tests developed to personalize medical decisions about cancer care are beneficial, while for others the evidence is uncertain and reliance on the test might even lead to poorer medical management of cancer in some cases, according new recommendation statements from an expert panel.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to New CDC study assesses impact of genetic testing on health outcomes
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account